logo
Weather page
GET THE APP
ePaper
google_play
app_store
  • Login
  • E-Edition
  • Sports
  • Obits
  • News
  • Opinion
  • Classifieds
    • Place an Ad
    • All Listings
    • Jobs
  • SPECIAL SECTIONS
  • GALLERY
  • CONTESTS
  • LIFESTYLE/ENTERTAINMENT
  • GAMES
  • Allegany County Source
    • News
      • local
      • state
      • nation/world
    • Sports
      • local
      • college
      • State
      • national
    • obits
    • Opinion
      • News
        • local
        • state
        • nation/world
      • Sports
        • local
        • college
        • State
        • national
      • obits
      • Opinion
    logo
    • Classifieds
      • Place an Ad
      • All Listings
      • Jobs
    • E-Edition
    • Subscribe
    • Login
      • Classifieds
        • Place an Ad
        • All Listings
        • Jobs
      • E-Edition
      • Subscribe
      • Login
    Home

    Olean Times Herald

    Posts
    Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
    Press Releases
    Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
    Crown Laboratories, Inc., Revance Therapeutics, Inc. 
    February 6, 2025
    The business combination reinforces Crown's position as a leading, innovative, high-growth aesthetics and skincare company JOHNSON CITY, Tenn. , Feb. ...
    Read More...
    {"website":"Website"}
    Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
    Press Releases
    Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
    Crown Laboratories, Inc., Revance Therapeutics, Inc. 
    January 31, 2025
    JOHNSON CITY, Tenn. and NASHVILLE,Tenn. , Jan. 31, 2025 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. (NASDAQ: RVN...
    Read More...
    {"website":"Website"}
    Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share
    Press Releases
    Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share
    Crown Laboratories, Inc., Revance Therapeutics, Inc. 
    December 12, 2024
    Board of Directors of Revance Recommend Stockholders Tender their Shares JOHNSON CITY, Tenn. , Dec. 12, 2024 /PRNewswire/ -- Crown Laboratories, Inc. ...
    Read More...
    {"website":"Website"}
    Local & Social

    Get in touch with Olean Times Herald

    Submit Content
    Send a Letter to the Editor Place Wedding Announcement Place Engagement Announcement
    Advertise
    Place Birth Announcement Place Anniversary Announcement Place Obituary
    Subscribe
    Start a Subscription e-Edition Contact Us
    Illinois Hancock Journal-Pilot Iroquois Times-Republic Journal-Republican The News-Gazette
    Indiana Fountain Co. Neighbor Herald Journal KV Post News Newton Co. Enterprise Rensselaer Republican Review-Republican
    Iowa Atlantic News Telegraph Audubon Advocate-Journal Barr's Post Card News Burlington Hawk Eye Collector's Journal Fayette County Union Ft. Madison Daily Democrat Independence Bulletin-Journal Keokuk Daily Gate City Oelwein Daily Register Vinton Newspapers Waverly Newspapers
    Michigan Iosco County News-Herald Ludington Daily News Oceana's Herald-Journal Oscoda Press White Lake Beacon New York Finger Lakes Times Olean Times Herald Salamanca Press
    Pennsylvania Bradford Era Clearfield Progress Courier Express Free Press Courier Jeffersonian Democrat Leader Vindicator Potter Leader-Enterprise The Wellsboro Gazette
    © Copyright Olean Times Herald 639 Norton Drive, Olean, NY 14760  | Terms of Use  | Privacy Policy
    Powered by TECNAVIA